Abstract
Infantile Tremor Syndrome (ITS) is categorically determined as a self-limiting clinical presentation which is characterized by anaemia, tremors, pigmentary skin disease, muscular hypotonia, and mental development regression. The presenting tremors are coarse in nature which are either decreased or vanished during sleep and takes 4-6 weeks duration for complete resolution following its natural course. The aetiology for ITS has been hypothesized for various factors like metabolic, infectious, nutritional but remained inconclusive for effective statement. But the precipitation is on the developing deficiency of Vitamin B12 but it remained controversial in terms of different factors. As the aetiology remained undefined, the line of treatment for children with ITS has been considered as per the treatment for undernourished child which included nutritional management with external supplementation of trace elements like iron, magnesium, calcium, vitamin B12 along with other such multivitamins. The administration of tremors is most commonly managed with the administration of propranolol or phenytoin, phenobarbitone, and carbamazepine. An 8 months old male child was brought by parents with complaints of fever since 8 days, decreased appetite and vomiting since 3 days. The course of hospital followed by physiotherapy which helped in regaining the normal functional activity of the baby.
Highlights
Infantile tremor syndrome (ITS) is a rare clinical disorder characterized by coarse tremors, anaemia and regression of motor and mental milestones
ITS is categorically determined as a self-limiting clinical presentation which is characterized by anaemia, tremors, pigmentary skin disease, muscular hypotonia, and mental development regression
The precipitation is on the developing deficiency of Vitamin B12 but it remained controversial in terms of different factors [3]
Summary
Siddharth Sunil Zabak, Ashish Ramesh Varma, Jayant Vagha, Anuj Ramesh Varma and Sakshi Pritam Arora4*. This work was carried out in collaboration among all authors. All authors read and approved the final manuscript. (1) Dr Barkat Ali Khan, Gomal University, Pakistan. Shreeyash Institute of Pharmaceutical Education and Research, India.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.